Skip to main content

Table 2 Univariable and multivariable analysis of parameters for progression-free survival

From: AST·MLR index and operation injury condition are novel prognostic predictor for the prediction of survival in patients with colorectal cancer liver metastases undergoing surgical resection

Parameters

Univariable analysis

Multivariable analysis

HR

95% CI

P value

HR

95% CI

P value

Age ≥ 60 years

0.993

0.783—1.260

0.957

   

Female

0.957

0.752—1.217

0.719

   

BMI ≥ 24 kg/m2

0.891

0.706—1.124

0.328

   

ASA score 1–2

1.051

0.724—1.526

0.794

   

Primary site colon

1.052

0.833—1.330

0.669

   

Right hemicolon

1.066

0.781—1.453

0.688

   

R0 resectiona

0.515

0.404—0.658

< 0.001*

0.583

0.453—0.748

< 0.001*

Poorly differentiateda

1.286

0.990—1.671

0.060

  

0.684

T3-T4a

1.490

0.935—2.374

0.093

  

0.262

N1-N2a

1.749

1.332—2.295

< 0.001*

1.511

1.145—1.994

0.004*

Synchronous metastasisa

1.451

1.087—1.937

0.012*

  

0.143

Extrahepatic metastasesa

1.612

1.160—2.239

0.004*

1.416

1.015—1.976

0.041*

Diameter of metastases > 5 cm

1.038

0.722—1.492

0.841

   

Multiple metastasesa

1.997

1.571—2.539

< 0.001*

  

0.063

Bilobar distributiona

2.035

1.603—2.583

< 0.001*

  

0.115

Preoperative CEA > 50 ng/mla

1.569

1.183—2.082

0.002*

1.400

1.053—1.861

0.021*

Major liver resectiona

1.978

1.563—2.503

< 0.001*

1.615

1.266—2.060

< 0.001*

Hepatectomy only

0.869

0.678—1.113

0.267

   

Radio frequency ablationa

1.818

1.289—2.565

0.001*

  

0.153

Preoperative chemotherapya

1.481

1.170—1.874

0.001*

  

0.204

Postoperative chemotherapy

0.870

0.689—1.098

0.241

   

Comorbidity

0.960

0.760—1.213

0.731

   

Postoperative complicationa

1.393

1.103—1.757

0.005*

  

0.161

Postoperative major complication

1.120

0.827—1.517

0.463

   

Serious operation injury conditiona

1.616

1.279—2.042

< 0.001*

  

0.062

AMLRI > 3.33a

1.530

1.114—2.101

0.009*

1.462

1.059—2.019

0.021 *

AST > 14 U/L

1.697

1.133—2.542

0.010*

   

MLR > 0.15

1.397

0.953—2.046

0.086

   

Blood loss (ml)

1.521

1.157—1.999

0.003*

   

Operation time (min)

1.572

1.240—1.993

< 0.001*

   

CRS 3–5

1.608

1.272—2.032

< 0.001*

   
  1. BMI body mass index, ASA American Society of Anesthesiologists T tumour staging, N lymph node staging, CEA carcinoembryonic antigen, CRS clinical risk score, AMLRI AST·MLR index, AST aspartate aminotransferase, MLR monocyte-to-lymphocyte ratio
  2. aIncluded in multivariable analysis
  3. *Statistically significant